🗞️ today in nature! Incredible work led by ⁦moran amit⁩ #OncSurgery ⁦MD Anderson Cancer Center⁩ translating our findings using #neoadjuvant #immunotherapy in #skin #CSCC cancer ⁦AACR⁩ ⁦NEJM⁩ into a novel understanding of cancer biology. nature.com/articles/s4158…

Just published in nature, Clements et al. reveal that axonal injury is a key driver of early GBM progression, overturning the assumption that early GBM growth is purely tumor-cell intrinsic and showing neurons profoundly shape GBM biology throughout their life cyle

Delighted to share our Cancer Cell paper published today, co-authored by Dr. Alexander Biederstädt Alexander Biederstädt, MD and Dr. Rafet Basar Rafet reporting the first genome-wide CRISPR screen in primary cord blood NK and CAR NK cells. We identify key genetic checkpoints including

Amazing work (as usual) from the Rezvani lab using a CRISPR screen to enhance CAR NK therapies. Congratulations to the whole team! Alexander Biederstädt, MD Rafet Katy Rezvani, M.D., Ph.D

Intriguing paper in nature demonstrating a mechanistic rationale for serine restriction in GBM. Congrats to Daniel Wahl and Drew Scott on this important advance

Excited to share our recent LancetOncology publication on sequential SBRT for oligometastatic clear cell RCC. Our outcomes show excellent outcomes in 121 patients with 1-5 metastases. MD Anderson Cancer Center Myriad Genetics authors.elsevier.com/a/1ljMf5EIIgTS…

Thanks Eric Topol for providing an excellent summary of our paper!